Chambal Fertilizers & Chemicals share price & results

Chambal Fertilizers & Chemicals Limited· Chemicals· Commodities

Results to: Sept 2026
Latest analysed call: Q1 FY27
Ownership as of: Sept 2026

India's largest private-sector urea manufacturer, running an integrated 3.4 MMTPA plant complex at Gadepan, Rajasthan.

Company research is public. Sign in to keep your own companies, notes and cases.

Inve AI Signals on CHAMBLFERT

Direct bridge to live research & tools watching Chambal Fertilizers & Chemicals Limited

Guidance Hit Rate

21 targets · 36% hit rate 4 achieved · 10 active →

Segment Shift

4 segments tracked See revenue & margin mix below →

Reverse DCF

Reality Gap Ready Test priced-in growth in DCF tool →

Concall & Tone

Q1 FY27 analysed Read claims, qualifiers & Q&A →

Price & Snapshot

₹389.35 −0.79% · −₹3.1

Last close 9 Nov 2026 · NSE · INR · Source: Inve

Performance −18.9% 1Y

1Y: ₹479.85 on 7 Nov 2025 → ₹389.35. High ₹490 (16 Jun 2026), low ₹353.9 (30 Oct 2026).

Previous close: ₹392.45
Market cap: ₹15.6k Cr
52-week range: ₹353.9 – ₹490
One year: −16.96%
Price to earnings (TTM to Sept 2026): 8.16×
Return on equity (TTM to Sept 2026): 16.83%

Reported

Key financial metrics & valuation ratios

Each figure keeps its basis and period; nothing is filled in.

Metric	Value	Change	Basis	Period	Note
Revenue	6,999 ₹ crore	+9.1% YoY	Quarterly, as filed	Quarter to Sept 2026	Revenue from operations as filed.
Operating margin	13.0 %	0.0 pts YoY	Operating profit / revenue	Quarter to Sept 2026	For the quarter; a change is in percentage points.
Net profit	635 ₹ crore	+5.5% YoY	Quarterly, as filed	Quarter to Sept 2026	Profit after tax as filed.
Return on equity	16.83 %	+1.0 ptsFY Mar 2026 vs FY Mar 2025	Trailing twelve months	TTM to Sept 2026	Adjusted profit attributable to owners ÷ average owners’ equity.
Free cash flow margin	-3.62 %	−8.6 ptsFY Mar 2026 vs FY Mar 2025	Fiscal year	FY ending Mar 2026	(Operating cash flow − fixed-asset purchases + disposals) ÷ revenue.
Revenue growth (YoY)	6.32 %	+32.3 ptsFY Mar 2026 vs FY Mar 2025	Trailing twelve months	TTM to Sept 2026	Revenue change against the same period one year earlier.

Source: Inve data from filed results; ratios from the Screener-verified panel · to Sept 2026

Business Mix

Where revenue comes from

Own Manufactured Fertilisers shrank from 87% to 57% of revenue over the last two years.

Own Manufactured Fertilisers 56.9% · ₹2,859.98 Cr −8.0% YoY

Complex Fertilisers 34.5% · ₹1,736.66 Cr −18.5% YoY

Crop Protection Chemicals, Speciality Nutrients and Seeds 8.6% · ₹430.38 Cr −6.1% YoY

Others 0.0% · ₹0.00 Cr

Explore full multi-period segment shift & margins →

Guidance

What management said, and what became of it

4 of 11 judged targets kept · 10 open · verdicts reflect calls analysed to Q1 FY27.

Target	Original wording	Said	Latest call	Verdict
Growth TAN Project Completion Date	October 2025 Call transcript, Q2 FY25 · 7 Nov 2024	Q2 FY25	Q1 FY27:Production of Weak Nitric Acid and Ammonium Nitrate solutions has commenced. Promise remains achieved. Call transcript, Q1 FY27 · 31 Jul 2026	Achieved
Capex IMACID Phosphoric Acid Capacity	Expand by 200,000 tons to 700,000 tons in 2.5 to 3 years (by mid-2027/early-2028) Call transcript, Q2 FY25 · 7 Nov 2024	Q2 FY25	Q1 FY27:The IMACID JV had a temporary shutdown due to sulphur shortages but has since resumed production. No specific update on the expansion project timeline was provided. Call transcript, Q1 FY27 · 31 Jul 2026	Ghosted
Products TERI Partnership Product Launches	Launch from FY 27-28 onwards Call transcript, Q3 FY26 · 11 Feb 2026	Q3 FY26	Q1 FY27:Management stated products are expected to be launched from FY '28-'29 onwards, a delay from the previous timeline of FY '27-'28. Call transcript, Q1 FY27 · 31 Jul 2026	Delayed

Source: Inve Guidance Tracker for Chambal Fertilizers & Chemicals Limited · to Q1 FY27

A verdict describes what became of management’s own words in later analysed calls. “Delayed” is a change of date, “went quiet” a target the calls stopped mentioning. None of it is a judgement on the investment. The methodology sets out how verdicts are recorded.

7 of Chambal Fertilizers & Chemicals Limited's 21 targets were missed. See which ones, and which are quietly gone. The 3 above are the free sample; 18 more targets are in the full ledger.

Free account: 5 full ledgers a month and one Inve Case. Pro opens 100 a month, ₹499.

See the full record

Supply chain

Cross-company call evidence

Named counterparties and similar headwinds disclosed on earnings calls.

Products, transactions and disclosed impact

Company disclosures with supporting evidence. Actual results, management expectations, and summary paraphrases remain qualified by source basis.

Commercial contract Stage: Signed Call date: 2026-05-15
1. Proposed
2. Announced
3. Active
4. Completed / ended
Named counterparties & directional relationship

Chambal Fertilizers & Chemicals Limited → sources products from → Nutrien

Party roles: Product recipient / Product source · Signed · Effective: very soon

Counterparty named; listed-company identity not verified.

Products, services & business exposure Mentioned in this disclosure

specialized nutrient use efficiency products (Nutrien's products) · role: not established · category: Materials / Agricultural input

Disclosed financial & operational figures

total market in India, as indicated by the issuer to Nutrien during their discussions: in the region of $1 billion · Disclosed operational measure · Geography · by the next 5 years

Additional disclosure context

Engagement status: Management says Nutrien are already more or less done in terms of engagement.
Agreement status qualifier: Management says the issuer has long-term agreements more or less in place.
Planned start: Management says the issuer will be starting with Nutrien's products very soon; no date is given.
Product description: Asked whether the products would be potash products, management answered no and described them as specialized nutrient use efficiency products.
Management market view: Management says agriculture is moving in a different direction and is no longer bulk.
Product characteristic unresolved referent: After a gap in the supplied excerpts, an unresolved 'it' is described as having content to increase soil carbon content and improving nutrient use efficiency; the referent is not shown in the supplied text.
Market sizing discussion: Management says that in talks with Nutrien, Nutrien asked what the total market in India is.
Hedged share remark: Management remarked, regarding what percentage Nutrien would be looking for, that maybe 10% would make a very large number; this is hedged and not stated as a target, commitment or issuer output.
Discussion context: The Nutrien remarks answered an analyst question framed around the CPC and biologic segment; management's answer does not itself state the segment assignment.
Evidence and remaining questions (Contextual assertion review)
Call date: 2026-05-15 · Review status: Contextual assertion review · Policy: context-loop-v2

Transcript excerpt
“So, we will be starting with their products”

Transcript excerpt
specialized nutrient use efficiency products (Nutrien's products): “They are specialized nutrient use efficiency products”

Transcript excerpt
in the region of $1 billion: “We indicated in the region of $1 billion by the next 5 years”

Transcript excerpt
“Nutrien are already more or less done in terms of engagement”
Transcript excerpt
“have got long-term agreements more or less in place”
Transcript excerpt
“So, we will be starting with their products very soon.”
Transcript excerpt
“No, no. They are specialized nutrient use efficiency products, very high”
Transcript excerpt
“the agriculture is moving in a different direction. It is no longer bulk.”
Transcript excerpt
“It has content to increase the carbon content in the soil.”
Transcript excerpt
“when we were talking to Nutrien, they said that, look, what is the total market in India?”
Transcript excerpt
“Maybe 10% would make a very large number”
Transcript excerpt
“last question on the CPC and biologic segment”

Not established by the available evidence
- joint_venture label vs narrative: The record is labelled joint_venture, but the Nutrien narrative describes only long-term agreements and starting with Nutrien's products. No venture vehicle, equity sharing or JV formation is stated for Nutrien, so no JV or ESTABLISHES edge is emitted. The only JV wording in the supplied passages concerns a separate possibility outside India with an unnamed party and is not linked to Nutrien. The label is unsupported rather than affirmatively contradicted.
- signed status vs hedged narrative: Raw status is 'signed', while management says the agreements are 'more or less in place' and engagement is 'more or less done'. This hedging is not an affirmative contradiction, so the label-derived SIGNED stage is kept. Confirmation of full execution is missing, and product sourcing has not yet started.
- binding effect: No definitive or binding preliminary instrument is described. 'Signed' and 'in place' alone do not establish binding effect.
- purchase, distribution, licence or manufacture terms: Only that the issuer will start with Nutrien's products is stated. Purchase, distribution, licence, exclusivity, volumes, pricing and term are not stated, so SOURCES_PRODUCTS_FROM is used without a more specific commercial predicate.
- contracting entities and other companies: The legal entities on each side, the number of agreements and whether Nutrien is the sole counterparty are unstated. 'We' is bound to the issuer via its management speaker. The analyst also named Corteva and Syngenta as companies discussed last quarter; no relation with them is stated for this disclosure, so none is emitted.
- specific products and category mapping: Specific product names are not given. MATERIALS/AGRICULTURAL_INPUT is mapped from 'nutrient use efficiency products' and the transcript's agriculture context. The offering role is UNDETERMINED because the transaction mechanism is not stated. Whether the soil-carbon description refers to these products is unresolved due to an excerpt gap.
- event geography: India appears in the summary rationale as the destination for the products and in the transcript as the market sized for Nutrien. No contracting or operating location is stated, so geography is null.
- effective date and term: No signing date, start date or term length is stated. 'Very soon' has no reference date, and 'long-term' gives no duration. call_date and report_date are disclosure metadata, not event dates.
- $1 billion market figure: The transcript gives 'in the region of $1 billion by the next 5 years' as the issuer's indication of the total market in India, which the summary calls a market opportunity. It is not a contract value, consideration, revenue or issuer output. The hedged 10% remark has no stated base and is not a measurement of the deal.
- consideration, contract value and impact: Consideration form is recorded as 'undisclosed' with a null amount. No contract value, volume, pricing or financial impact is stated. The analyst asked how big this could get for the issuer's output, and the answer gave only market sizing and a hedged percentage, so no impact is emitted.

Relationship Lifecycle

Counterparties named by Chambal Fertilizers & Chemicals Limited

Chambal Fertilizers & Chemicals Limited → partners with → Nutrien.

Q4 FY26 · Announced · Positive · Counterparty named; listed-company identity not verified.
1. Proposed
2. Announced
3. Active
4. Completed / ended
Long-term agreements in place to bring specialized nutrient use efficiency products to India, addressing the $1 billion market opportunity.

“So, I would tell you that Nutrien are already more or less done in terms of engagement. We have got long-term agreements more or less in place. So, we will be starting with their products very soon.”

Exact commercial direction is not specified; disclosed as a partnership or collaboration.

Evidence drawer

Evidence type: Transcript excerpt

“So, I would tell you that Nutrien are already more or less done in terms of engagement. We have got long-term agreements more or less in place. So, we will be starting with their products very soon.”

Source company: Chambal Fertilizers & Chemicals Limited · Counterparty: Nutrien · Call date: 2026-05-15 · Period: Q4 FY26 · Review status: Structured call extraction
Chambal Fertilizers & Chemicals Limited → partners with → TERI.

Q4 FY26 · Announced · Positive · Counterparty named; listed-company identity not verified.
1. Proposed
2. Announced
3. Active
4. Completed / ended
Established CFCL - TERI Centre of Excellence for Advanced and Sustainable Agricultural Solutions, focusing on R&D of next generation agricultural technologies.

“Additionally, we partnered with TERI to establish the CFCL - TERI Centre of Excellence for Advanced and Sustainable Agricultural Solutions, which will focus on research and development of next generation agricultural technologies.”

Exact commercial direction is not specified; disclosed as a partnership or collaboration.

Evidence drawer

Evidence type: Transcript excerpt

“Additionally, we partnered with TERI to establish the CFCL - TERI Centre of Excellence for Advanced and Sustainable Agricultural Solutions, which will focus on research and development of next generation agricultural technologies.”

Source company: Chambal Fertilizers & Chemicals Limited · Counterparty: TERI · Call date: 2026-05-15 · Period: Q4 FY26 · Review status: Structured call extraction

Similar pressures reported by peers

Tailwind coverage is not available yet.

Similar commentary provides sector context; it does not establish a business relationship with Chambal Fertilizers & Chemicals Limited. Each comparison matches a headwind disclosed by Chambal Fertilizers & Chemicals Limited in the same calendar reporting quarter.

Geopolitical uncertainties, elevated raw material prices, and a delayed onset of the…

Topic: Raw material costs · Raw material cost · Q1 FY27

Chambal Fertilizers & Chemicals Limited reported: Geopolitical uncertainties, elevated raw material prices, and a delayed onset of the southwest monsoon created a challenging environment.

Reporting period ended 2026-06-30

47 other companies · Raw material cost

Pidilite Industries Limited (PIDILITIND) reported (period ended 2026-06-30): VAM prices fluctuated sharply, increasing to $1,370 in Q1 from $800 in Q4 FY26, impacting gross margins.
Coromandel International Limited (COROMANDEL) reported (period ended 2026-06-30): Increased subsidy rates did not fully compensate for the rise in global raw material costs, impacting production and imports of NP/NPK fertilizers.
PI Industries Limited (PIIND) reported (period ended 2026-06-30): Demand challenges and high input costs are creating pressure on pricing and margins across the Agchem industry, requiring careful balance.
Deepak Nitrite Limited (DEEPAKNTR) reported (period ended 2026-06-30): Management acknowledged raw material volatility but stated proactive procurement and operational efficiencies helped manage it in Q1, expecting global competitiveness.

Evidence drawer

Evidence type: Summary paraphrase

Geopolitical uncertainties, elevated raw material prices, and a delayed onset of the southwest monsoon created a challenging environment.

Source company: Chambal Fertilizers & Chemicals Limited · Reporting period ended 2026-06-30 · Calendar quarter: Q1 FY27 · Distinct companies matched: 47

Similar commentary provides sector context; it does not establish a business relationship.

From available earnings-call summaries. Disclosures are management statements, not independently verified transactions.

Live Summary

CHAMBLFERT ₹389.35 −0.79%

Guidance Verdict (21 tracked) 4 kept · 10 open· 7 missed

AI Call Brief · Q1 FY27

Chambal Fertilizers & Chemicals Limited Q1 FY27

Overview

Symbol: NSE:CHAMBLFERT
Sector: Chemicals
Industry: Commodities
Exchange: NSE
Currency: INR

What Chambal Fertilizers & Chemicals Limited does

Based on the company's own presentations, annual report and earnings calls.

Chambal Fertilisers and Chemicals Limited manufactures urea at an integrated three-plant complex in Gadepan, Rajasthan, and markets complex fertilisers (DAP, MOP, TSP, NPK blends), crop protection chemicals, speciality nutrients, biologicals and seeds under an asset-light distribution model, mostly under the "Uttam" brand. It also holds a stake in the IMACID joint venture in Morocco with OCP that manufactures phosphoric acid (P2O5), and is commissioning a new Technical Ammonium Nitrate (TAN) plant at Gadepan to diversify into industrial and mining chemicals.

Segments

Urea
Complex Fertilisers
CPC, Speciality Nutrients & Seeds
Industrial and Mining Chemicals (TAN)

Urea manufacturing capacity: 3.4 MMTPA
Urea manufacturing plants: 3 (Gadepan-I, II, III), single location
Years of industry presence: 40+
Market position: No. 1 private-sector urea manufacturer in India
Urea market share: ~10%
States covered: 14

Founded 1985Headquarters Gadepan, District Kota, Rajasthan (Registered Office); Corporate Office in Jasola, New Delhi Company website

How the price took the results

Moved an average of ±3.4% across the last 3 priced result releases

Close before → close after

Quarter	Release	Revenue (₹ Cr)	Net profit (₹ Cr)	Rev YoY	Before → After	Reaction
Q1 FY27	31 Jul 26	5,027	703	−11.8%	₹445.85 → ₹438.9	−1.6%
Q4 FY26	15 May 26	2,785	145	+13.7%	₹424.6 → ₹449.9	+6.0%
Q3 FY26	11 Feb 26	5,898	565	+19.9%	₹453.75 → ₹465.45	+2.6%

The move from the last close before each results date to the first close on or after it — the market's first read on the quarter alongside what was filed.

Guidance

What management said, and what became of it

4 of 11 judged targets kept · 10 open · verdicts reflect calls analysed to Q1 FY27.

Target	Original wording	Said	Latest call	Verdict
Growth TAN Project Completion Date	October 2025 Call transcript, Q2 FY25 · 7 Nov 2024	Q2 FY25	Q1 FY27:Production of Weak Nitric Acid and Ammonium Nitrate solutions has commenced. Promise remains achieved. Call transcript, Q1 FY27 · 31 Jul 2026	Achieved
Capex IMACID Phosphoric Acid Capacity	Expand by 200,000 tons to 700,000 tons in 2.5 to 3 years (by mid-2027/early-2028) Call transcript, Q2 FY25 · 7 Nov 2024	Q2 FY25	Q1 FY27:The IMACID JV had a temporary shutdown due to sulphur shortages but has since resumed production. No specific update on the expansion project timeline was provided. Call transcript, Q1 FY27 · 31 Jul 2026	Ghosted
Products TERI Partnership Product Launches	Launch from FY 27-28 onwards Call transcript, Q3 FY26 · 11 Feb 2026	Q3 FY26	Q1 FY27:Management stated products are expected to be launched from FY '28-'29 onwards, a delay from the previous timeline of FY '27-'28. Call transcript, Q1 FY27 · 31 Jul 2026	Delayed

Source: Inve Guidance Tracker for Chambal Fertilizers & Chemicals Limited · to Q1 FY27

The full ledger

Open Chambal Fertilizers & Chemicals Limited’s full ledger

A free account opens 5 company ledgers a month. All 21 tracked commitments, with each call’s wording and source.

Browse the register

Latest analysed call: Q1 FY27, 31 Jul 2026. 8 calls analysed.

No analysed call after Q1 FY27, though results run to Sept 2026.

Call summaries

Q1 FY27 — 31 Jul 2026

Chambal Fertilizers & Chemicals Limited Q1 FY27

Chambal Fertilizers & Chemicals Limited reported a challenging Q1 FY27 with a 12% revenue decline to INR 5,000 crores, primarily due to geopolitical issues, high raw material costs, and delayed monsoon impacting sales. Despite this, the company achieved significant margin expansion, with EBITDA rising 12% to INR 851 crores (17% margin) and PAT growing 10% to INR 703 crores (14% margin), driven by prudent procurement and a diversified business model. The Technical Ammonium Nitrate project progressed well, and the new Urea Investment Policy 2026 offers a strong framework for future growth.

Read the full call

Q4 FY26 — 15 May 2026

Chambal Fert. Q4 FY26

Chambal Fertilisers and Chemicals Limited reported a robust Q4 and FY26, marked by strong revenue and PAT growth, particularly in the Complex Fertilizer segment. The company made significant progress on its TAN project and expanded its product portfolio. However, challenges included a decline in Urea segment revenue, increased receivables, and volatility in raw material prices due to geopolitical tensions and import dependence.

Read the full call

Q3 FY26 — 11 Feb 2026

Chambal Fert. Q3 FY26

Chambal Fertilisers reported a strong Q3 FY26, with standalone revenue growing 20% YoY to INR 5,898 crores, driven by robust performance in complex fertilizers and value-added segments. The company continued its momentum in crop protection chemicals and biologicals, with significant growth in volumes and revenues. The Technical Ammonium Nitrate (TAN) project is 92% complete and on track for April 2026 commissioning, while the company is also exploring vertical and horizontal expansions.

Read the full call

Summaries of each call, in Inve’s own words; the transcript is not reproduced. Not investment advice.

Every analysed call

Chambal Fertilizers & Chemicals Limited earnings calls (CHAMBLFERT)

Fundamentals

Valuation, return & balance-sheet ratios

Current values with the period they cover; the trend reads across the 6 fiscal years held (Mar 2021 to Mar 2026).

Trailing twelve months
19.82% TTM to Sept 2026
Fiscal year
25.17% FY ending Mar 2026

Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
20.40% 23.39% 16.05% 20.20% 26.76% 25.17%

How it is calculated. Adjusted EBIT ÷ average capital employed, including minority equity and deposits.
Trailing twelve months
16.83% TTM to Sept 2026
Fiscal year
19.95% FY ending Mar 2026

Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
32.32% 26.73% 14.93% 16.99% 18.96% 19.95%

How it is calculated. Adjusted profit attributable to owners ÷ average owners’ equity.
Trailing twelve months
10.36% TTM to Sept 2026
Fiscal year
14.79% FY ending Mar 2026

Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
12.11% 13.23% 7.71% 10.03% 13.24% 14.79%

How it is calculated. Total profit excluding exceptional items after tax ÷ average total assets.
Trailing twelve months
13.52% TTM to Sept 2026
Fiscal year
12.96% FY ending Mar 2026

Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
19.42% 14.10% 6.56% 11.39% 15.02% 12.96%

How it is calculated. Operating profit ÷ revenue.
Trailing twelve months
9.23% TTM to Sept 2026
Fiscal year
9.18% FY ending Mar 2026

Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
11.79% 9.69% 3.62% 6.78% 9.11% 9.18%

How it is calculated. Total profit excluding exceptional items after tax ÷ revenue.
Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
52.74% -1.17% 10.96% 15.13% 4.95% -3.62%

How it is calculated. (Operating cash flow − fixed-asset purchases + disposals) ÷ revenue.
Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
397.25% -1.53% 313.25% 260.74% 84.54% 7.07%

How it is calculated. Operating cash flow ÷ reported total net profit.
Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
1.86% 1.11% 0.71% 3.41% 3.44% 4.29%

How it is calculated. Fixed-asset purchases ÷ revenue.
Trailing twelve months
6.32% TTM to Sept 2026
Fiscal year
24.92% FY ending Mar 2026

Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
4.20% 26.34% 72.84% -35.31% -7.35% 24.92%

How it is calculated. Revenue change against the same period one year earlier.
Trailing twelve months
2.63% TTM to Sept 2026
Fiscal year
25.84% FY ending Mar 2026

Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
24.47% 9.63% -35.45% 21.19% 24.55% 25.84%

How it is calculated. Adjusted profit attributable to owners vs the same period one year earlier.
Trailing twelve months
10.06% TTM to Sept 2026
Fiscal year
7.72% FY ending Mar 2026

Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
28.31% -8.30% -19.56% 12.35% 22.18% 7.72%

How it is calculated. Operating profit vs the same period one year earlier.
Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
0.75× 0.68× 0.48× 0.26× 0.01× 0.10×

How it is calculated. Borrowings ÷ owners’ equity.
Trailing twelve months
60.44× TTM to Sept 2026
Fiscal year
364.43× FY ending Mar 2026

Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
7.96× 21.35× 5.30× 11.41× 50.02× 364.43×

How it is calculated. Adjusted EBIT ÷ interest expense.
Trailing twelve months
1.12× TTM to Sept 2026
Fiscal year
1.61× FY ending Mar 2026

Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
1.03× 1.37× 2.13× 1.48× 1.45× 1.61×

How it is calculated. Revenue ÷ average total assets.
Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
₹3,029.00 Cr ₹3,783.00 Cr ₹3,300.00 Cr ₹1,741.00 Cr ₹-137.00 Cr ₹511.00 Cr

How it is calculated. Borrowings less cash equivalents.
Trailing twelve months
0.50× TTM to Sept 2026
Fiscal year
0.18× FY ending Mar 2026

Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
1.16× 1.44× 1.65× 0.76× -0.05× 0.18×

How it is calculated. (Borrowings − cash equivalents) ÷ adjusted EBITDA.
Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
2.36× 1.84× 1.84× 1.67× 1.31× 1.24×

How it is calculated. Average total assets ÷ closing owners’ equity.
Trailing twelve months
8.16× TTM to Sept 2026
Fiscal year
8.17× FY ending Mar 2026

Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
— — — — — —

How it is calculated. Current market cap ÷ adjusted profit attributable to owners for the selected income period. Uses current market cap, not the share price at the period end.
Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
— — — — — —

How it is calculated. Market cap ÷ owners’ equity from the balance sheet selected for the TTM inputs. Uses current market cap, not the share price at the period end.
Trailing twelve months
5.76× TTM to Sept 2026
Fiscal year
5.56× FY ending Mar 2026

Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
— — — — — —

How it is calculated. (Market cap + borrowings + deposits − cash equivalents) ÷ adjusted EBITDA. Uses current market cap, not the share price at the period end.
Trailing twelve months
15.21% TTM to Sept 2026
Fiscal year
15.83% FY ending Mar 2026

Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
— — — — — —

How it is calculated. Adjusted EBIT ÷ enterprise value. Uses current market cap, not the share price at the period end.
Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
34.00 days 49.00 days 23.00 days 4.00 days 8.00 days 36.00 days

How it is calculated. Reported receivable days from the annual accounts.
Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
39.00 days 119.00 days 25.00 days 42.00 days 71.00 days 63.00 days

How it is calculated. Reported inventory days, using material cost / cost of goods sold.
Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
19.00 days 57.00 days 22.00 days 27.00 days 25.00 days 26.00 days

How it is calculated. Reported payable days, using material cost / cost of goods sold.
Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
54.00 days 111.00 days 26.00 days 19.00 days 54.00 days 73.00 days

How it is calculated. Reported debtor days plus inventory days less payable days.
Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
21.00 days 39.00 days 8.00 days -0.00 days 30.00 days 41.00 days

How it is calculated. Reported net working capital days from the annual accounts.
Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
19.00% 20.00% 30.00% 24.00% 24.00% 23.00%

How it is calculated. Reported dividend payout as a percentage of annual profit.
Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
— — — — — —

How it is calculated. Market capitalisation from the current stock record.

Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
20.40%	23.39%	16.05%	20.20%	26.76%	25.17%

Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
32.32%	26.73%	14.93%	16.99%	18.96%	19.95%

Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
12.11%	13.23%	7.71%	10.03%	13.24%	14.79%

Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
19.42%	14.10%	6.56%	11.39%	15.02%	12.96%

Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
11.79%	9.69%	3.62%	6.78%	9.11%	9.18%

Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
52.74%	-1.17%	10.96%	15.13%	4.95%	-3.62%

Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
397.25%	-1.53%	313.25%	260.74%	84.54%	7.07%

Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
1.86%	1.11%	0.71%	3.41%	3.44%	4.29%

Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
4.20%	26.34%	72.84%	-35.31%	-7.35%	24.92%

Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
24.47%	9.63%	-35.45%	21.19%	24.55%	25.84%

Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
28.31%	-8.30%	-19.56%	12.35%	22.18%	7.72%

Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
0.75×	0.68×	0.48×	0.26×	0.01×	0.10×

Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
7.96×	21.35×	5.30×	11.41×	50.02×	364.43×

Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
1.03×	1.37×	2.13×	1.48×	1.45×	1.61×

Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
₹3,029.00 Cr	₹3,783.00 Cr	₹3,300.00 Cr	₹1,741.00 Cr	₹-137.00 Cr	₹511.00 Cr

Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
1.16×	1.44×	1.65×	0.76×	-0.05×	0.18×

Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
2.36×	1.84×	1.84×	1.67×	1.31×	1.24×

Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
—	—	—	—	—	—

Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
—	—	—	—	—	—

Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
—	—	—	—	—	—

Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
—	—	—	—	—	—

Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
34.00 days	49.00 days	23.00 days	4.00 days	8.00 days	36.00 days

Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
39.00 days	119.00 days	25.00 days	42.00 days	71.00 days	63.00 days

Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
19.00 days	57.00 days	22.00 days	27.00 days	25.00 days	26.00 days

Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
54.00 days	111.00 days	26.00 days	19.00 days	54.00 days	73.00 days

Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
21.00 days	39.00 days	8.00 days	-0.00 days	30.00 days	41.00 days

Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
19.00%	20.00%	30.00%	24.00%	24.00%	23.00%

Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
—	—	—	—	—	—

A dash means inputs are missing or too old, the ratio does not apply, or the value is outside the supported range. FY uses the reported fiscal period; TTM the latest twelve months; valuations use the current market cap with the chosen earnings period. Screen Indian stocks on these ratios →

Financials

Quarterly & annual financial statements

Net profit, year on year: +5% (quarter to sept 2026 against sept 2025).

Dec 2024	Mar 2025	Jun 2025	Sept 2025	Dec 2025	Mar 2026	Jun 2026	Sept 2026
4,918	2,449	5,698	6,413	5,898	2,785	5,027	6,999
4,140	2,285	4,936	5,571	5,077	2,530	4,176	6,099
778	164	761	842	821	255	851	901
16.0%	7.0%	13.0%	13.0%	14.0%	9.0%	17.0%	13.0%
64	55	168	40	14	29	182	51
7	0	2	1	1	3	17	22
83	82	84	87	88	90	89	100
753	137	843	795	746	191	927	829
33.0%	27.0%	24.0%	24.0%	24.0%	24.0%	24.0%	23.0%
504	100	638	602	565	145	703	635
12.59	2.49	15.92	15.02	14.09	3.63	17.56	15.85

Source: Inve data · income statement, quarterly · to Sept 2026

Sales 3Y CAGR −9.2%

Operating profit 3Y CAGR +13.9%

Net profit 3Y CAGR +23.5%

Mar 2023	Mar 2024	Mar 2025	Mar 2026
27,773	17,967	16,646	20,794
25,957	15,922	14,162	18,114
1,815	2,044	2,484	2,679
229	253	353	251
320	173	48	7
308	312	330	349
1,416	1,812	2,460	2,575
1,034	1,201	1,656	1,950

Source: Inve data · income statement, annual · to Mar 2026

Mar 2023	Mar 2024	Mar 2025	Sept 2025	Mar 2026	Sept 2026
416	401	401	401	401	401
6,460	6,723	8,134	9,438	9,787	10,902
3,279	1,794	16	100	976	1,680
2,358	2,377	2,596	3,914	2,945	5,336
12,514	11,293	11,147	13,853	14,108	18,319
6,262	6,423	6,221	6,090	6,110	7,508
103	184	650	1,135	1,389	61
2,140	2,235	1,131	952	806	303
4,008	2,452	3,144	5,676	5,804	10,446
12,514	11,293	11,147	13,853	14,108	18,319

Source: Inve data · balance sheet · to Sept 2026

Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
6,951	-33	3,241	3,328	1,395	139
-255	-119	-1,873	-384	739	-474
-5,943	-213	-1,862	-2,871	-2,135	543
753	-364	-494	73	-2	208
6,715	-196	3,047	2,720	825	-753

Source: Inve data · cash flow · to Mar 2026

Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
34	49	23	4	8	36
39	119	25	42	71	63
19	57	22	27	25	26
54	111	26	19	54	73
20	39	8	0	30	41
20.0%	21.0%	17.0%	21.0%	28.0%	26.0%
23.0%	24.0%	29.0%	23.0%	24.0%	23.0%

Source: Inve data · annual ratios · to Mar 2026

Where revenue comes from

The businesses behind the company’s reported revenue.

Reporting basis Reporting period

Own Manufactured Fertilisers contributes 56.9% of reported segment revenue.

Quarter ended 30 Jun 2026 · Consolidated

Own Manufactured Fertilisers 56.9%

₹2,859.98 crore
Complex Fertilisers 34.5%

₹1,736.66 crore
Crop Protection Chemicals, Speciality Nutrients and Seeds 8.6%

₹430.38 crore
Others 0.0%

₹0.00 crore

Reported business segments for quarter ended 30 Jun 2026
Business segment	Revenue · ₹ crore	Share
Own Manufactured Fertilisers	2,859.98	56.9%
Complex Fertilisers	1,736.66	34.5%
Crop Protection Chemicals, Speciality Nutrients and Seeds	430.38	8.6%
Others	0.00	0.0%

Share = segment revenue ÷ total segment revenue, before intersegment adjustments.

How these numbers add up

Total segment revenue: ₹5,027.02 crore
Intersegment adjustment: ₹0.00 crore
Net segment revenue: ₹5,027.02 crore

Intersegment transactions are between the company’s own businesses. Net segment revenue can differ from income-statement revenue because reporting definitions differ.

Source: FinEdge · Last checked 19 Sept 2026. Reported segment names are kept as supplied.

How the mix has moved

Own Manufactured Fertilisers shrank from 87% to 57% of revenue over the last two years.

CHAMBLFERT revenue by business segment, share of consolidated revenue by quarter
Segment	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026	YoY growth latest quarter
Own Manufactured Fertilisers	87%	74%	92%	55%	52%	63%	87%	57%	-8.0%
Complex Fertilisers	6%	21%	7%	37%	42%	31%	12%	35%	-18.5%
Crop Protection Chemicals, Speciality Nutrients and Seeds	—	—	—	8%	—	6%	1%	9%	-6.1%
Others	0%	0%	0%	0%	0%	0%	0%	0%	—

Share of reported segment revenue by quarter, consolidated basis, as filed. A quarter the company did not report is left blank, never carried forward.

See how segments are shifting across companies → Segment Shift

Ownership

Who owns it — shareholding pattern

Promoters hold 61.72% as of Sept 2026; institutions cut 0.52 pts since Jun 2026.

Promoters +0.38 pts 61.72%
Foreign institutions −1.51 pts 13.41%
Domestic institutions +0.99 pts 6.33%
Public +0.16 pts 18.56%
Others 0.00 pts 0.00%

2,61,108 shareholders on the register.

Source: Exchange shareholding filings · to Sept 2026 · 8 filings held

Who was buying across the market this quarter

Who bought this quarter

since Jun 2026

Disclosed holders that added to a position or appeared on the register for the first time, biggest addition first.

+3.40 pp 3.47% held
Mutual fund newly disclosed 2.61% held
+0.18 pp 3.74% held
newly disclosed 0.17% held

The same filing shows 0 holders trimming and 2 off the list — both are in the register beside this.

Who is on the register

Named in the Sep 2026 filing

Every holder of Chambal Fertilizers & Chemicals Limited above SEBI's 1% disclosure line, and what changed since Jun 2026.

Holder	Stake	Change
	14.28%	unchanged
	14.22%	unchanged
	8.19%	unchanged
	3.74%	+0.18 pp
	3.47%	+3.40 pp
Mutual fund	2.61%	newly disclosed
	2.03%	unchanged
	1.90%	unchanged
	1.72%	unchanged
	1.66%	unchanged
	1.64%	unchanged
	1.58%	unchanged

A holder disappearing from this list has fallen below the 1% line — it is not necessarily a sale. Percentages are of total shares, as disclosed in the company's own filing. Who was buying across the market this quarter.

Mutual funds in CHAMBLFERT

Filings to Sep 2026

0 new, 0 added, 5 trimmed, 0 sold out — net −0.13 L shares (−0.1%).

Held by funds: ₹600 Cr; 10 schemes
Biggest holder: HDFC Small Cap Fund; ₹351 Cr · 0.9% of that fund

Scheme	Holding	Last month	Held since
HDFC Small Cap Fund HDFC Mutual Fund	₹351 Cr	held	Dec '22
Nippon India Small Cap Fund Nippon India Mutual Fund	₹166 Cr	held	Dec '19
HDFC Retirement Fund - Hybrid-Equity Plan HDFC Mutual Fund	₹35 Cr	held	Dec '22
HDFC Balanced Advantage Fund HDFC Mutual Fund	₹25 Cr	held	Jan '26
Nippon India Nifty Smallcap 250 Index Fund Nippon India Mutual Fund	₹9 Cr	−0.07 L	Oct '20
HDFC Dividend Yield Fund HDFC Mutual Fund	₹7 Cr	held	Dec '22
SBI Nifty Smallcap 250 Index Fund SBI Mutual Fund	₹5 Cr	−0.04 L	Oct '22
Nippon India Nifty 500 Equal Weight Index Fund Nippon India Mutual Fund	₹1 Cr	−0.01 L	Sep '24

HDFC, Nippon India and SBI schemes, from their monthly disclosures. Changes are counted in shares, so a price move never looks like buying or selling.

Mutual funds Sep 2026

0 added, 5 trimmed — net −12,556 shares (−0.1%)

Funds are sitting on: +31%; vs est. average cost
Held by funds: ₹600 Cr; 10 schemes · ≈ 3.7% of the company
Biggest holder: HDFC Small Cap Fund; ₹351 Cr · 0.9% of that fund
Longest holder: Nippon India Small Cap Fund; 6y 10m · since Dec '19

Shares held by these funds −25%

Oct '23 1.47 cr shares Sep '26

Your own record

Start an Inve Case for Chambal Fertilizers & Chemicals Limited

Free account: one company. Everything above stays public.

Write why you follow Chambal Fertilizers & Chemicals Limited and the condition you want checked. Inve compares your numeric conditions with available results and management guidance; your own conditions remain yours to review.

What an account adds

Keep reading

Other Chemicals companies

PEER COMPARISON

Median ₹15,599 Cr Mkt Cap

All Chemicals companies → · Chemicals earnings growth →

Quick Answers

Frequently asked questions on Chambal Fertilizers & Chemicals Limited

Compiled directly from CHAMBLFERT's filed financial statements, earnings call transcripts, and ownership disclosures.

How did Chambal Fertilizers & Chemicals Limited (CHAMBLFERT) perform in its latest reported quarter (Sept 2026)?

For the quarter ended Sept 2026, Chambal Fertilizers & Chemicals Limited reported revenue of ₹7.0k Cr, net profit of ₹635 Cr, an operating margin of 13.0%. Diluted earnings per share stood at ₹15.85.

How is Chambal Fertilizers & Chemicals Limited (CHAMBLFERT) valued today, and what growth does the stock price imply?

Chambal Fertilizers & Chemicals Limited (CHAMBLFERT) trades at ₹389.35, with a market capitalization of ₹15.6k Cr. Reverse-DCF analysis shows the current stock price implies -3.8% annual earnings growth over the next 7 years compared with its historical net-profit CAGR of 21.1%.

Who owns Chambal Fertilizers & Chemicals Limited (CHAMBLFERT) — promoters, FIIs, DIIs, and mutual funds?

As of Sept 2026, Promoters hold 61.7%, FIIs hold 13.4%, DIIs hold 6.3%, Public shareholders hold 18.6%.

Learn to analyse Chambal Fertilizers & Chemicals Limited

Guides on how to read this kind of business and the numbers that matter.

Chambal Fertilizers & Chemicals share price & results

Performance −18.9% 1Y

Key financial metrics & valuation ratios

Where revenue comes from

What management said, and what became of it

Cross-company call evidence

Products, transactions and disclosed impact

Counterparties named by Chambal Fertilizers & Chemicals Limited

Similar pressures reported by peers

What Chambal Fertilizers & Chemicals Limited does

How the price took the results

What management said, and what became of it

Open Chambal Fertilizers & Chemicals Limited’s full ledger

Q1 FY27 — 31 Jul 2026

Q4 FY26 — 15 May 2026

Q3 FY26 — 11 Feb 2026

Chambal Fertilizers & Chemicals Limited earnings calls (CHAMBLFERT)

Valuation, return & balance-sheet ratios

Quarterly & annual financial statements

Where revenue comes from

How the mix has moved

Reverse DCF: growth rate implied by today's share price

Multiples & returns vs own history

Who owns it — shareholding pattern

Who bought this quarter

Who is on the register

Mutual funds in CHAMBLFERT

Start an Inve Case for Chambal Fertilizers & Chemicals Limited

Other Chemicals companies

Frequently asked questions on Chambal Fertilizers & Chemicals Limited

Learn to analyse Chambal Fertilizers & Chemicals Limited